posted on 2012-10-24, 09:00authored byJulia Stoute, Gabriela M. Almeida, A. Rapp, Karen J. Bowman, George D. D. Jones, ECVAG
The Comet assay (CA) is a sensitive/simple measure of genotoxicity. However, many features of CA contribute variability. To minimize these, we have introduced internal standard materials consisting of 'reference' cells which have their DNA substituted with BrdU. Using a fluorescent anti-BrdU antibody, plus an additional barrier filter, comets derived from these cells could be readily distinguished from the 'test'-cell comets, present in the same gel. In experiments to evaluate the reference cell comets as external and internal standards, the reference and test cells were present in separate gels on the same slide or mixed together in the same gel, respectively, before their co-exposure to X-irradiation. Using the reference cell comets as internal standards led to substantial reductions in the coefficient of variation (CoV) for intra- and inter-experimental measures of comet formation and DNA damage repair; only minor reductions in CoV were noted when the reference and test cell comets were in separate gels. These studies indicate that differences between individual gels appreciably contribute to CA variation. Further studies using the reference cells as internal standards allowed greater significance to be obtained between groups of replicate samples. Ultimately, we anticipate that development will deliver robust quality assurance materials for CA.
Funding
This work was supported by Cancer Research UK project
grant (C13560/A4661) awarded to GDDJ and also by two
Type B Research Projects ‘Assessment and reduction of
comet assay variation in relation to DNA damage and
DNA repair phenotype’ and ‘Assessment and reduction
of comet assay variation in relation to DNA damage’
from ECNIS (Environmental Cancer Risk, Nutrition
and Individual Susceptibility) [a network of excellence operating within the European Union Sixth Framework
Program, Priority 5: ‘Food Quality and Safety’ (Contract
No 513943)] awarded to the European Comet Assay
Validation Group (ECVAG). MZ is supported by the
Public Service Department of Malaysia and the Institute
for Medical Research, Malaysia. GMA is supported by
FCT, Portugal, and the European Social Fund. Funding
for open access charge: Grant funding.
History
Citation
Nucleic Acids Research, 2009, 37 (22), pp. e150-e150